November 29, 2019

News You Need - 3 Big Little Things from HealthXL - December 2019

Announcements/News
Chandana Fitzgerald
&

We have collected and reviewed the three most noteworthy news stories in digital health from last month and explained their relevance below. What they mean for the industry, and why you should know about them. You also have an opportunity to reach out to me if you wish to connect with our friends from the industry who know the ins and outs so you can quite literally ‘get behind the headlines’. 


1: Biofourmis announce acquisition of Biovotion and partnership with Novartis.

Story snapshot: This month, Biofourmis announced the acquisition of Biovotion. The acquisition includes all of Biovotion's assets, including the Everion biosensor and 60+ global patents, covering most of the wearable and sensor technology that exists for the arm or hand, as well as Biovotion's staff, partners, and clients. On top of this, Biofourmis have just announced a partnership with Novartis on the use of a predictive analytics platform (BiovitalsHF) in combination with the Everion sensor to monitor heart failure patients.

Why is it notable?


Industry Implications:

Kuldeep Singh Rajput
Kuldeep Singh Rajput
Founder & CEO
Biofourmis

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

2: Google just bought Fitbit.

Story snapshot: I am sure you heard - Google has bought Fitbit for a whopping $2.1 billion. We debated writing about it this week because the healthcare implications are not that obvious yet. But then again, this is Google, and the healthcare participation will certainly follow. So, here goes.


Why is it notable?  

 

Industry Implications:

Bernard N.
Bernard N.
VP Head of Global Medical & Clinical Affairs
Bayer

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

3: Pear Therapeutics has a new pharma partnership with Ironwood Pharmaceuticals.


Story snapshot: Pear Therapeutics has entered a partnership with Ironwood Pharmaceuticals to bring to market prescription digital therapeutics (PDT) for gastrointestinal (GI)indications.


Why is it notable?

Industry Implications:

Yuri Maricich MD MBA
Yuri Maricich MD MBA
Chief Medical Officer and Head of Development
Pear Therapeutics

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.